Cargando…
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
Amplicon-based next generation sequencing (NGS) approaches have been preferentially adopted by the clinical laboratories on the basis of a short turnaround time (TAT) and small DNA input needs. However, little work has been done to assess the amplicon-based NGS methods for copy number variation (CNV...
Autores principales: | Niu, Dongfeng, Li, Lei, Yu, Yang, Zang, Wanchun, Li, Zhongwu, Zhou, Lixin, Jia, Ling, Rao, Guanhua, Gao, Lianju, Cheng, Gang, Ji, Ke, Lin, Dongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471150/ https://www.ncbi.nlm.nih.gov/pubmed/32621174 http://dx.doi.org/10.1007/s12253-020-00844-w |
Ejemplares similares
-
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
por: Liu, Zimin, et al.
Publicado: (2021) -
Comparative Studies of Copy Number Variation Detection Methods for Next-Generation Sequencing Technologies
por: Duan, Junbo, et al.
Publicado: (2013) -
Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
por: Gao, Jing, et al.
Publicado: (2017) -
Allele-specific copy number profiling by next-generation DNA sequencing
por: Chen, Hao, et al.
Publicado: (2015) -
Personalized Copy-Number and Segmental Duplication Maps using Next-Generation Sequencing
por: Alkan, Can, et al.
Publicado: (2009)